- Tytuł:
- Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom
- Autorzy:
- Źródło:
- In The Lancet Regional Health - Europe February 2024 37
Czasopismo naukowe